Research output per year
Research output per year
Personal profile
Research Interests
Anti-cancer therapeutics
Neuro oncology
Gynaecological cancers
Genitourinary cancers
Rare cancers - cancer of unknown primary, endocrine cancers and others
Supportive care
Neuro oncology
Gynaecological cancers
Genitourinary cancers
Rare cancers - cancer of unknown primary, endocrine cancers and others
Supportive care
Research Expertise
Cancer
Cancer Pharmacology
Education/Academic qualification
PhD, Flinders University
External positions
Clinical lead, Statewide Cancer Clinical Network, Government of South Australia, Commission on Excellence and Innovation in Health
2019 → …
SALHN, Southern Adelaide Local Health Network
Supervision
- Registered
Research Areas
- Clinical
Supervisory Interests
- Quality use of medicines
- Personalised medicine
- Anticancer
Fingerprint
Dive into the research topics where Ganessan Kichenadasse is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A lack of association between BMI and chemoimmunotherapy efficacy in advanced non-small cell lung cancer: Secondary analysis of the IMpower150 and IMpower130 clinical trials
Li, L. X., Socinski, M. A., Kichenadasse, G., Karapetis, C. S., Shahnam, A., McKinnon, R. A., Rowland, A., Hopkins, A. M. & Sorich, M. J., 25 Mar 2024, In: BMC Cancer. 24, 1, 8 p., 379.Research output: Contribution to journal › Article › peer-review
Open AccessFile26 Downloads (Pure) -
A phase II trial of nivolumab followed by ipilimumab and nivolumab in advanced non-clear-cell renal cell carcinoma
Conduit, C., Davis, I. D., Goh, J. C., Kichenadasse, G., Gurney, H., Harris, C. A., Pook, D., Krieger, L., Parnis, F., Underhill, C., Adams, D., Roncolato, F., Joshua, A., Ferguson, T., Prithviraj, P., Morris, M., Harrison, M., Begbie, S., Hovey, E., George, M., & 6 others, Feb 2024, In: BJU International. 133, S3, p. 57-67 11 p.Research output: Contribution to journal › Article › peer-review
-
BCAT1, IKZF1 and SEPT9: methylated DNA biomarkers for detection of pan-gastrointestinal adenocarcinomas
Laven-Law, G., Kichenadasse, G., Young, G. P., Symonds, E. L. & Winter, J. M., 2024, In: Biomarkers. 29, 4, p. 194-204 11 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile2 Citations (Scopus)23 Downloads (Pure) -
CDK9 inhibition inhibits multiple oncogenic transcriptional and epigenetic pathways in prostate cancer
Rahman, R., Rahaman, M. H., Hanson, A. R., Choo, N., Xie, J., Townley, S. L., Shrestha, R., Hassankhani, R., Islam, S., Ramm, S., Simpson, K. J., Risbridger, G. P., Best, G., Centenera, M. M., Balk, S. P., Kichenadasse, G., Taylor, R. A., Butler, L. M., Tilley, W. D., Conn, S. J., & 3 others, 8 Aug 2024, (E-pub ahead of print) In: British Journal of Cancer. 14 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile11 Downloads (Pure) -
Clinical and functional outcomes for risk-appropriate treatments for prostate cancer
Tiruye, T., O'Callaghan, M., Ettridge, K., Moretti, K., Jay, A., Higgs, B., Santoro, K., Kichenadasse, G. & Beckmann, K., Jan 2024, In: BJUI Compass. 5, 1, p. 109-120 12 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile4 Citations (Scopus)61 Downloads (Pure)
Activities
- 1 Oral presentation
-
Utility of a self-management approach in lifestyle interventions for cancer survivors - preliminary findings from the NAPA trial
Sharon Lawn (Speaker), Stephanie Zrim (Speaker), Stephanie Leggett (Speaker), Michelle Miller (Speaker), L Jones (Speaker), Jim Dollman (Speaker), Sue Booth (Speaker), Richard Woodman (Speaker), Chris Karapetis (Speaker), Ganessan Kichenadasse (Speaker), Shawgi Sukumaran (Speaker) & Bogda Koczwara (Speaker)
6 Feb 2013Activity: Talk or presentation types › Oral presentation